Narrow search
Showing 1 - 10 of 113
Cover Image
Does reference pricing drive out generic competition in pharmaceutical markets? : evidence from a policy reform
Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune - 2022
entry by generic producers. Reference pricing shifts demand towards generics but also induces the branded producer to become …
Persistent link: https://www.econbiz.de/10013285854
Cover Image
Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform
Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune - 2022
entry by generic producers. Reference pricing shifts demand towards generics but also induces the branded producer to become …
Persistent link: https://www.econbiz.de/10013353465
Cover Image
Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2010
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using … prices and market shares of brand-names and generics. Then, we exploit a detailed panel data set at product level covering …-savings, and that patients' copayments decrease despite the extra surcharges under RP. …
Persistent link: https://www.econbiz.de/10010274913
Cover Image
Price Regulation and Parallel Imports of Pharmaceuticals
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2015
This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a theory model where the producer price is subject to bargaining between the brand-name producer and a distributor, we show that the effects of stricter price regulation crucially...
Persistent link: https://www.econbiz.de/10011307132
Cover Image
Margins and market shares: Pharmacy incentives for generic substitution
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2012
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we … copayments. Second, we exploit a unique product level panel data set, which contains information on sales and prices at both … generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …
Persistent link: https://www.econbiz.de/10010291561
Cover Image
Price Regulation and Parallel Imports of Pharmaceuticals.
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - Institutt for samfunnsøkonomi, Norges Handelshøyskole … - 2014
This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. First, we develop a theory model in which a pharmacy negotiates producer prices with a brand-name firm and then sets retail prices. We show that the effects of price regulation...
Persistent link: https://www.econbiz.de/10010818874
Cover Image
Price Regulation and Parallel Imports of Pharmaceuticals
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - Núcleo de Investigação em Políticas Económicas … - 2014
This paper studies the effects of price regulation and parallel imports in the onpatent pharmaceutical market. First, we develop a theory model in which a pharmacy negotiates producer prices with a brand-name firm and then sets retail prices. We show that the effects of price regulation...
Persistent link: https://www.econbiz.de/10010897779
Cover Image
Margins and market shares: Pharmacy incentives for generic substitution
Brekke, Kurt Richard; Holmås, Tor Helge; Straume, Odd Rune - In: European Economic Review 61 (2013) C, pp. 116-131
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we … copayments. Second, we exploit a unique product level panel data set, which contains information on sales and prices at both … generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …
Persistent link: https://www.econbiz.de/10011048555
Cover Image
Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment
Brekke, Kurt R.; Holmas, Tor Helge; Straume, Odd Rune - In: Journal of Public Economics 95 (2011) 7, pp. 624-638
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using … prices and market shares of brand-names and generics. Then, we exploit a detailed panel data set at product level covering …-savings, and that patients' copayments decrease despite the extra surcharges under RP. …
Persistent link: https://www.econbiz.de/10010574320
Cover Image
Regulation, generic competition and pharmaceutical prices: Theory and evidence from a natural experiment
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - Núcleo de Investigação em Políticas Económicas … - 2008
We study the impact of regulatory regimes on generic competition and pharmaceutical pricing using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. We exploit a detailed panel dataset at product level...
Persistent link: https://www.econbiz.de/10005827125